Review



cd8a 2 bioxcell be0061 2 43 cd8a 2 apc tonbo biosciences 20 1886 u100 2 43 cd8a  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell cd8a 2 bioxcell be0061 2 43 cd8a 2 apc tonbo biosciences 20 1886 u100 2 43 cd8a
    Cd8a 2 Bioxcell Be0061 2 43 Cd8a 2 Apc Tonbo Biosciences 20 1886 U100 2 43 Cd8a, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 661 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/InVivoMAb+anti-mouse+CD8%CE%B1/pm41555085-357-170-171
    Average 97 stars, based on 661 article reviews
    cd8a 2 bioxcell be0061 2 43 cd8a 2 apc tonbo biosciences 20 1886 u100 2 43 cd8a - by Bioz Stars, 2026-11
    97/100 stars

    Images

    Related Articles

    Mouse Assay:

    Article Title: Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.
    Article Snippet: After 72 h of activation, CD8+ T cell culture supernatants were collected, stored at −20 °C and quantified using mouse TNF ELISA (R&D systems, MTA00B). .. Mice were intraperitoneally injected with 200 μg anti-CD8a (Bio X Cell, BE0061, RRID: AB_1125541), anti-CXCR3 (Bio X Cell, BE0249, RRID: AB_2687730), rat IgG2b isotype control (Bio X Cell, BE0090, RRID: AB_1107780) or Armenian hamster IgG isotype control (Bio X Cell, BE0091, RRID: AB_1107773) six times, on days −1, 1, 5, 9, 13 and 16 relative to subcutaneous tumor injection (day 0). ..

    Article Title: FGFR pathway inhibition enhances PD-1 blockade and modulates antitumor immunity in colorectal cancer models.
    Article Snippet: The areas positive for PD-1, CD8, and IFNg were quantified using SlideViewer software (version 2.9.0; 3DHISTECH, Budapest, Hungary). .. Mice were intraperitoneally injected with 200 μg (10 mg/ kg) anti-mouse CD8 antibody (Bio X Cell, BE0061) or Rat IgG2b isotype control (Bio X cell, BE0090) two days before treatment and 2, 6 and 10 days after treatment, respectively. ..

    Injection:

    Article Title: Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.
    Article Snippet: After 72 h of activation, CD8+ T cell culture supernatants were collected, stored at −20 °C and quantified using mouse TNF ELISA (R&D systems, MTA00B). .. Mice were intraperitoneally injected with 200 μg anti-CD8a (Bio X Cell, BE0061, RRID: AB_1125541), anti-CXCR3 (Bio X Cell, BE0249, RRID: AB_2687730), rat IgG2b isotype control (Bio X Cell, BE0090, RRID: AB_1107780) or Armenian hamster IgG isotype control (Bio X Cell, BE0091, RRID: AB_1107773) six times, on days −1, 1, 5, 9, 13 and 16 relative to subcutaneous tumor injection (day 0). ..

    Article Title: Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
    Article Snippet: For neutrophil depletion, CRLM mice were treated with 200 μg anti-IgG (intraperitoneally, every 3 days, clone 2A3, Bio X Cell, RRID: AB_1107769) or 200 μg anti-Ly6G (intraperitoneally, every 3 days, clone 1A8, Bio X Cell, RRID: AB_1107721). .. For CD8 + T-cell depletion, 200 μg anti-mouse CD8a (Bio X Cell, BE0061, RRID: AB_1125541) was injected intraperitoneally twice a week. ..

    Article Title: FGFR pathway inhibition enhances PD-1 blockade and modulates antitumor immunity in colorectal cancer models.
    Article Snippet: The areas positive for PD-1, CD8, and IFNg were quantified using SlideViewer software (version 2.9.0; 3DHISTECH, Budapest, Hungary). .. Mice were intraperitoneally injected with 200 μg (10 mg/ kg) anti-mouse CD8 antibody (Bio X Cell, BE0061) or Rat IgG2b isotype control (Bio X cell, BE0090) two days before treatment and 2, 6 and 10 days after treatment, respectively. ..

    Article Title: Targeting PRPF19 suppresses lung cancer progression by abrogating cytokinesis and potentiating anti-tumor immunity
    Article Snippet: .. For CD8 T cell depletion, C57BL/6 mice bearing KP-1 allografts were randomly assigned to groups and injected intraperitoneally (i.p.) with anti-CD8 neutralizing antibody (100 μg/mouse, BE0061, BioXCell) or equal volume of PBS every 3 days starting one day before tumor inoculation. .. For CXCR3 blockade, tumor-bearing C57BL/6 mice were treated with AMG 487 (5 mg/kg, T10297L, TargetMol) or vehicle control by twice daily subcutaneous injection from day 1 to day 20 after tumor inoculation.

    Control:

    Article Title: Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy.
    Article Snippet: After 72 h of activation, CD8+ T cell culture supernatants were collected, stored at −20 °C and quantified using mouse TNF ELISA (R&D systems, MTA00B). .. Mice were intraperitoneally injected with 200 μg anti-CD8a (Bio X Cell, BE0061, RRID: AB_1125541), anti-CXCR3 (Bio X Cell, BE0249, RRID: AB_2687730), rat IgG2b isotype control (Bio X Cell, BE0090, RRID: AB_1107780) or Armenian hamster IgG isotype control (Bio X Cell, BE0091, RRID: AB_1107773) six times, on days −1, 1, 5, 9, 13 and 16 relative to subcutaneous tumor injection (day 0). ..

    Article Title: FGFR pathway inhibition enhances PD-1 blockade and modulates antitumor immunity in colorectal cancer models.
    Article Snippet: The areas positive for PD-1, CD8, and IFNg were quantified using SlideViewer software (version 2.9.0; 3DHISTECH, Budapest, Hungary). .. Mice were intraperitoneally injected with 200 μg (10 mg/ kg) anti-mouse CD8 antibody (Bio X Cell, BE0061) or Rat IgG2b isotype control (Bio X cell, BE0090) two days before treatment and 2, 6 and 10 days after treatment, respectively. ..

    Immune Cell:

    Article Title: Blocking aryl hydrocarbon receptor remodels myeloid-T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment.
    Article Snippet: .. To selectively deplete immune cell subsets, depletion antibodies (400 μg) were administered intraperitoneally twice a week, beginning one day before treatment, as follows: anti-CD8 (clone 2.43, BioXCell; Lebanon, NH), anti-CD4 (clone GK1.5, BioXCell), and anti-NK1.1 (clone PK136, BioXCell). .. Macrophage depletion was achieved through intraperitoneal administration of 300 μg of antiCSF1R (clone AFS98, BioXCell) on alternate days.

    In Vivo:

    Article Title: Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner
    Article Snippet: The ICIs were anti-PD-1 (clone RMP1-14), anti-PD-L1 (clone 10F.9G2), and anti-CTLA-4 (clone UC10-4F10-11) (Bio X Cell, NH, USA). .. For in vivo depletion of T cells, 200 μg of anti-CD8α (clone 2.43) or anti-CD4 (clone GK1.5) (Bio X Cell) was administered intraperitoneally 2 days before tumor inoculation and 4 days before treatment initiation. ..

    Article Title: Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy.
    Article Snippet: In situ generation of autologous tumor vaccines from dying tumor cells offers a promising route for personalized cancer immunotherapy, yet is often limited by phosphatidylserine (PS)-mediated immunosuppressive clearance that can restrict downstream immune activation and favor M2-like macrophage polarization.. Here, we report a sequentially orchestrated nanovaccine (NT@ANX5-P) that couples photodynamic therapy (PDT)-induced immunogenic tumor-cell damage with ondemand PS masking to enhance in situ tumor vaccination.. The nanovaccine consists of a photosensitizer core cloaked with genetically engineered tumor cell membranes displaying Annexin A5 (ANX5) and further shielded by a ROS-cleavable PEG layer for circulatory shielding and local light-responsive activation.

    Tumor Implantation:

    Article Title: Targeting PRPF19 suppresses lung cancer progression by abrogating cytokinesis and potentiating anti-tumor immunity
    Article Snippet: .. For CD8 T cell depletion, C57BL/6 mice bearing KP-1 allografts were randomly assigned to groups and injected intraperitoneally (i.p.) with anti-CD8 neutralizing antibody (100 μg/mouse, BE0061, BioXCell) or equal volume of PBS every 3 days starting one day before tumor inoculation. .. For CXCR3 blockade, tumor-bearing C57BL/6 mice were treated with AMG 487 (5 mg/kg, T10297L, TargetMol) or vehicle control by twice daily subcutaneous injection from day 1 to day 20 after tumor inoculation.



    Similar Products

    93
    Proteintech gb21303 apc anti mouse cd8a antibody proteintech
    Gb21303 Apc Anti Mouse Cd8a Antibody Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-mouse+CD8a/pm42810343-283-261-266
    Average 93 stars, based on 1 article reviews
    gb21303 apc anti mouse cd8a antibody proteintech - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    91
    Cytek Biosciences cd8a
    Cd8a, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-Human+CD8a/10__1021_slash_acsnano__6c11865-448-42-46
    Average 91 stars, based on 1 article reviews
    cd8a - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd8 apc
    Anti Cd8 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/CD8a+Antibody%2C+anti-mouse%2C+REAfinity/pmc13355016-9-0-2
    Average 94 stars, based on 1 article reviews
    anti cd8 apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology cd8a apc
    Cd8a Apc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-Rat+CD8a+Antibody/pm41612708-289-13-17
    Average 94 stars, based on 1 article reviews
    cd8a apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology apc anti mouse cd8a antibody
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Apc Anti Mouse Cd8a Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-Mouse+CD8a+Antibody/pmc13053763-26-0-5
    Average 94 stars, based on 1 article reviews
    apc anti mouse cd8a antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology e ab f1104e rrid ab 3740201
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    E Ab F1104e Rrid Ab 3740201, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-Mouse+CD8a+Antibody/pmc13053763-26-8-5
    Average 94 stars, based on 1 article reviews
    e ab f1104e rrid ab 3740201 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Proteintech anti cd8a
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Anti Cd8a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-mouse+CD3/pm41748617-317-15-14
    Average 93 stars, based on 1 article reviews
    anti cd8a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    ABclonal Biotechnology apc rat anti mouse cd8a
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Apc Rat Anti Mouse Cd8a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/CD8A+Rabbit+pAb/pm41734761-926-16-14
    Average 95 stars, based on 1 article reviews
    apc rat anti mouse cd8a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Proteintech apc coupled cd8a antibody
    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells <t>(CD8A</t> + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.
    Apc Coupled Cd8a Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-mouse+CD8a/pmc12992596-312-43-48
    Average 93 stars, based on 1 article reviews
    apc coupled cd8a antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Proteintech anti cd8 apc
    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells <t>(CD8A</t> + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.
    Anti Cd8 Apc, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/apc+cd8a/APC+Anti-human+CD8a/pm41588655-69-47-49
    Average 94 stars, based on 1 article reviews
    anti cd8 apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured CD8 + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured CD8 + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Inhibition, Cell Culture, Control, Expressing

    Knockdown of LDHA/B inhibits HCC growth by activating CD8 + T cell-mediated antitumor immunity (A) WB analysis of LDHA, LDHB, and β-actin (loading control) expression in control and LDHA/B DKO Hepa 1–6 cells. (B) Representative images of tumors dissected from tumor-bearing mice ( n = 6). Tumor weights (C), tumor growth curves (D), Kaplan-Meier survival curve ( n = 6) (E), and lactate contents in tumor tissues (F) of the control and LDHA/B DKO groups ( n = 6). (G) IHC staining of H3K18la and Pan Kla in tumor tissues (scale bars, 100 μm, n = 6). (H–M) FC analysis of tumor-infiltrating immune cells: TILs were isolated from control and LDHA/B-DKO tumors. FC plots (left) and quantitative statistics (right) show: the proportion of CD3 + CD8 + CTLs (H), the proportion of CD44hiCD62Llo effector memory CTLs (I), and the proportions of intratumoral GzMB + (J), and IFN-γ + (K) CTLs with representative scatterplots ( n = 6). Cell aggregates and debris were first excluded, followed by gating on the target cell populations and markers of interest. Representative FC plots and quantitative data are presented. (L and M) Tumor size and growth curves of mice treated with anti-CD8 antibody to deplete CD8 + T cells or isotype control (IgG) ( n = 6). (N) Mouse body weights at the end of the experiment ( n = 6). Data are presented as mean ± SD. (C–F, and H–M) were analyzed using Student’s t test, and (N) was analyzed by two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001; ns, not significant. All experiments were repeated three times. β-actin served as the loading control for WB experiments.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: Knockdown of LDHA/B inhibits HCC growth by activating CD8 + T cell-mediated antitumor immunity (A) WB analysis of LDHA, LDHB, and β-actin (loading control) expression in control and LDHA/B DKO Hepa 1–6 cells. (B) Representative images of tumors dissected from tumor-bearing mice ( n = 6). Tumor weights (C), tumor growth curves (D), Kaplan-Meier survival curve ( n = 6) (E), and lactate contents in tumor tissues (F) of the control and LDHA/B DKO groups ( n = 6). (G) IHC staining of H3K18la and Pan Kla in tumor tissues (scale bars, 100 μm, n = 6). (H–M) FC analysis of tumor-infiltrating immune cells: TILs were isolated from control and LDHA/B-DKO tumors. FC plots (left) and quantitative statistics (right) show: the proportion of CD3 + CD8 + CTLs (H), the proportion of CD44hiCD62Llo effector memory CTLs (I), and the proportions of intratumoral GzMB + (J), and IFN-γ + (K) CTLs with representative scatterplots ( n = 6). Cell aggregates and debris were first excluded, followed by gating on the target cell populations and markers of interest. Representative FC plots and quantitative data are presented. (L and M) Tumor size and growth curves of mice treated with anti-CD8 antibody to deplete CD8 + T cells or isotype control (IgG) ( n = 6). (N) Mouse body weights at the end of the experiment ( n = 6). Data are presented as mean ± SD. (C–F, and H–M) were analyzed using Student’s t test, and (N) was analyzed by two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001; ns, not significant. All experiments were repeated three times. β-actin served as the loading control for WB experiments.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Knockdown, Control, Expressing, Immunohistochemistry, Isolation

    KIF20A regulates PD-L1 expression via c-Myc (A and B) Huh7 and HCCLM3 cells were transfected with KIF20A small interfering RNAs (siRNAs) or KIF20A overexpression (OE) pcDNA3.1 plasmids, respectively. The protein levels of KIF20A, c-Myc, and PD-L1 were measured by WB in Huh7 and HCCLM3 cells. (C) ChIP-PCR was performed to assess the binding of c-Myc to the PD-L1 promoter region in Huh7 cells. (D) Huh7 cells were transfected with c-Myc siRNAs, and the knockdown efficiency of c-Myc was verified by RT-PCR. (E and F) Huh7 and HCCLM3 cells were co-transfected with KIF20A OE plasmids and c-Myc siRNAs. The protein levels of KIF20A, PD-L1, and c-Myc were determined by WB. (G) Huh7 cells were co-transfected with pGL3-PD-L1 or pGL3-basic plasmids, KIF20A OE pcDNA3.1 plasmids, c-Myc siRNAs, and pRL-TK plasmids, followed by luciferase activity assay. (H and I) KIF20A promotes HCC cell immune evasion by regulating PD-L1 expression via c-Myc. HCC cells from different groups were co-cultured with CD8 + T cells. Representative FC plots and quantitative analysis of GzMB and IFN-γ expression in CD8 + T cells co-cultured with Huh7 cells. (J and K) Representative images and quantitative analysis of colony formation in Huh7 cells with or without CD8 + T cell co-culture. Data are presented as mean ± SD. Statistical analyses were performed using Student’s t test (D), one-way ANOVA (C, I), or two-way ANOVA (G, K). ∗∗ p < 0.01 and ∗∗∗ p < 0.001. All experiments were repeated three times.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: KIF20A regulates PD-L1 expression via c-Myc (A and B) Huh7 and HCCLM3 cells were transfected with KIF20A small interfering RNAs (siRNAs) or KIF20A overexpression (OE) pcDNA3.1 plasmids, respectively. The protein levels of KIF20A, c-Myc, and PD-L1 were measured by WB in Huh7 and HCCLM3 cells. (C) ChIP-PCR was performed to assess the binding of c-Myc to the PD-L1 promoter region in Huh7 cells. (D) Huh7 cells were transfected with c-Myc siRNAs, and the knockdown efficiency of c-Myc was verified by RT-PCR. (E and F) Huh7 and HCCLM3 cells were co-transfected with KIF20A OE plasmids and c-Myc siRNAs. The protein levels of KIF20A, PD-L1, and c-Myc were determined by WB. (G) Huh7 cells were co-transfected with pGL3-PD-L1 or pGL3-basic plasmids, KIF20A OE pcDNA3.1 plasmids, c-Myc siRNAs, and pRL-TK plasmids, followed by luciferase activity assay. (H and I) KIF20A promotes HCC cell immune evasion by regulating PD-L1 expression via c-Myc. HCC cells from different groups were co-cultured with CD8 + T cells. Representative FC plots and quantitative analysis of GzMB and IFN-γ expression in CD8 + T cells co-cultured with Huh7 cells. (J and K) Representative images and quantitative analysis of colony formation in Huh7 cells with or without CD8 + T cell co-culture. Data are presented as mean ± SD. Statistical analyses were performed using Student’s t test (D), one-way ANOVA (C, I), or two-way ANOVA (G, K). ∗∗ p < 0.01 and ∗∗∗ p < 0.001. All experiments were repeated three times.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Expressing, Transfection, Over Expression, Binding Assay, Knockdown, Reverse Transcription Polymerase Chain Reaction, Luciferase, Activity Assay, Cell Culture, Co-Culture Assay

    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells (CD8A + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells (CD8A + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Expressing, Immunohistochemical staining, Staining

    ACAT2 expression in HCeEpiC and CC cell lines was examined using RT-qPCR A and Western blot analysis B ( n = 5 independent experiments). C ACAT2, DHCR7, and MSMO1 expression in CC cells after infection with Scramble-sh, ACAT2-sh #1, and ACAT2-sh #2 was examined using Western blot analysis ( n = 5 independent experiments). D Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in CC cells ( n = 5 independent experiments). The proliferation of CC cells was examined using CCK8 ( E ) and colony formation assays F (n = 5 independent experiments). G CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 T cells for 6 h, respectively, and the death of CC cells was detected ( n = 5 independent experiments). H IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , B ) or two-way ( C - H ) ANOVA, followed by Tukey’s multiple comparisons test ( A – H ).

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: ACAT2 expression in HCeEpiC and CC cell lines was examined using RT-qPCR A and Western blot analysis B ( n = 5 independent experiments). C ACAT2, DHCR7, and MSMO1 expression in CC cells after infection with Scramble-sh, ACAT2-sh #1, and ACAT2-sh #2 was examined using Western blot analysis ( n = 5 independent experiments). D Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in CC cells ( n = 5 independent experiments). The proliferation of CC cells was examined using CCK8 ( E ) and colony formation assays F (n = 5 independent experiments). G CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 T cells for 6 h, respectively, and the death of CC cells was detected ( n = 5 independent experiments). H IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , B ) or two-way ( C - H ) ANOVA, followed by Tukey’s multiple comparisons test ( A – H ).

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Infection, Cell Culture, Co-Culture Assay, Enzyme-linked Immunosorbent Assay

    A ACAT2 knockdown efficiency in U14 cells was examined using western blot analysis ( n = 10 independent experiments). B Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells (n = 10 animals). C The images and weight of the tumors harvested on day 21 ( n = 10 animals). D Protein expression of ACAT2, MSMO1, DHCR7, and PCNA in transplanted tumors was examined using western blot analysis ( n = 10 animals). E Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in transplanted tumors ( n = 10 animals). The gating strategy for GZMB + NK cells and CD8 + T cells F and quantification G were analyzed using flow cytometry ( n = 10 animals). H Survival of mice over 60 days after subcutaneous inoculation of U14 cells was analyzed using the log-rank test ( n = 20 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , C , E , G ) or two-way ( B , D ) ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A ACAT2 knockdown efficiency in U14 cells was examined using western blot analysis ( n = 10 independent experiments). B Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells (n = 10 animals). C The images and weight of the tumors harvested on day 21 ( n = 10 animals). D Protein expression of ACAT2, MSMO1, DHCR7, and PCNA in transplanted tumors was examined using western blot analysis ( n = 10 animals). E Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in transplanted tumors ( n = 10 animals). The gating strategy for GZMB + NK cells and CD8 + T cells F and quantification G were analyzed using flow cytometry ( n = 10 animals). H Survival of mice over 60 days after subcutaneous inoculation of U14 cells was analyzed using the log-rank test ( n = 20 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , C , E , G ) or two-way ( B , D ) ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Knockdown, Western Blot, Expressing, Flow Cytometry

    The proliferation of CC cells was examined using CCK8 A and colony formation assays B ( n = 5 independent experiments). C CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 + T cells, and the death of CC cells was detected ( n = 5 independent experiments). D IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). E TGF-β1 released by CC cells was examined using ELISA ( n = 5 independent experiments). F PD-L1 expression levels in CC cells were observed using immunofluorescence staining ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the two-way ( A – F ) ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: The proliferation of CC cells was examined using CCK8 A and colony formation assays B ( n = 5 independent experiments). C CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 + T cells, and the death of CC cells was detected ( n = 5 independent experiments). D IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). E TGF-β1 released by CC cells was examined using ELISA ( n = 5 independent experiments). F PD-L1 expression levels in CC cells were observed using immunofluorescence staining ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the two-way ( A – F ) ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Cell Culture, Co-Culture Assay, Enzyme-linked Immunosorbent Assay, Expressing, Immunofluorescence, Staining

    A Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells ( n = 5 animals). B The images and weight of the tumors harvested on day 21 ( n = 5 animals). The gating strategy for GZMB + NK cells and CD8 + T cells C and quantification D were analyzed using flow cytometry ( n = 5 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( B , D ) or two-way A ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells ( n = 5 animals). B The images and weight of the tumors harvested on day 21 ( n = 5 animals). The gating strategy for GZMB + NK cells and CD8 + T cells C and quantification D were analyzed using flow cytometry ( n = 5 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( B , D ) or two-way A ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Flow Cytometry